Show simple item record

dc.contributor.authorGharehaghaji, N
dc.contributor.authorDivband, B
dc.date.accessioned2018-08-26T06:34:38Z
dc.date.available2018-08-26T06:34:38Z
dc.date.issued2018
dc.identifier10.22038/nmj.2018.05.003
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/44035
dc.description.abstractObjective (s): In this study, the zeolite-coated iron oxide nanoparticles were evaluated as MRI contrast agent and effect of the nanocomposite synthesis method on MRI contrast was tested. Materials and Methods: Ion exchange method was used for synthesis of iron oxide-zeolite and the as prepared nanocomposite was characterized by XRD, FESEM and TEM. The nanocomposite toxicity in the cell culture, and then their effect on MRI contrast were investigated. Results: The results showed a properly crystallized nanocomposite with the size of 120-180 nm. Iron oxide nanoparticles were capsulated in the pores of the zeolite. A very small amount of the nanoparticles were placed on the composite outer surface that led to enough free space on the zeolite surface. The nanocomposite was not toxic for the cell line and its MRI r2 relaxivity was calculated 127.14 mM-1s-1. Conclusion: Iron oxide-zeolite nanocomposite synthesized by ion exchange method is introduced as an MRI T2 contrast agent with a great potential for drug loading purposes.
dc.language.isoEnglish
dc.relation.ispartofNANOMEDICINE JOURNAL
dc.subjectContrast
dc.subjectIon exchange
dc.subjectIron oxide nanoparticles
dc.subjectMRI
dc.subjectZeolite
dc.titleA novel MRI contrast agent synthesized by ion exchange method
dc.typeArticle
dc.citation.volume5
dc.citation.issue1
dc.citation.spage15
dc.citation.epage18
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.22038/nmj.2018.05.003


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record